← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Owner-earnings 10-yr IRR 10–30 points over Treasuries, yield ≤ 25% · bought the day of the annual report, held 12 months
Could be luck Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +2.9 pts (823 entries, 256 companies, could be luck). 47% of entries beat the S&P; 18% beat it by 30 points or more; 27% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +1.2 pts.
+2.9 ptsvs S&P, average
47%beat the S&P
18%up 30+ pts vs S&P
27%down 20+ pts vs S&P
+6.0 ptsvs small caps, 12 mo
−14.6 pts 2024worst year to buy ?
1.8luck check ?
Does the holding period matter?3 mo: −0.5 pts 47% beat6 mo: +0.1 pts 45% beat12 mo: +2.9 pts 47% beat24 mo: +3.3 pts 42% beat3 yr, per yr: −0.9 pts 39% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today686+1.9 pts t 1.2+5.3 pts
Sell-off (S&P ≥10% off high)137+7.9 pts t 1.4+9.6 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing256+0.9 pts t 0.4−5.1 pts
Retail & consumer106+10.5 pts t 1.9+1.9 pts
Services78−3.2 pts t -0.5−2.1 pts
Energy69+3.1 pts t 0.5−4.9 pts
Other61−4.4 pts t -0.8−3.3 pts
Tech hardware & semis58−2.8 pts t -0.6−1.4 pts
Finance & real estate46+5.9 pts t 1.5+6.8 pts
Biotech & pharma28−5.0 pts t -0.7−4.3 pts

Holds up out of sample? Before 2018: +5.1 pts (n 291, t 2.3). From 2018: +1.7 pts (n 532, t 0.8). Same sign in both halves.

Year201120122013201420152016201720182019202020212022202320242025
vs S&P−11 pts+5 pts+6 pts−5 pts−4 pts+17 pts+8 pts−10 pts−14 pts+46 pts+8 pts+8 pts−14 pts−15 pts+3 pts
n12943515570425362725676876957

Read the research behind this screen: Ranking companies as equity bonds: the top fifth beats the bottom fifth by a wide margin → · Test your own combination in the Screen Lab →

Same definitions as the table: coupon = 3-yr average owner earnings, growth capped, 15× exit. Historical IRR uses a 5-yr revenue CAGR as the growth proxy where the DCF rate is not available point-in-time. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

ATNM
Actinium Pharmaceuticals, Inc.
Below Treasuries
Healthcare Risk 43 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +89.9%/yr vs model +2.0% · above model
ATOM
Atomera Inc
Below Treasuries
Technology Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +133.6%/yr vs model +2.0% · above model
ATOS
ATOSSA THERAPEUTICS, INC.
Below Treasuries
Healthcare Risk 34 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ATS
ATS Corp /ATS
Below Treasuries
Industrials Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
ATYR
aTYR PHARMA INC
Below Treasuries
Healthcare Risk 26 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +82.5%/yr vs model +15.0% · above model
AUC
ATIF Holdings Ltd
Below Treasuries
Industrials Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +107.1%/yr vs model +2.0% · above model
AUGO
Aura Minerals Inc.
Below Treasuries
Basic Materials Risk 48 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AUNA
AUNA S.A.
Below Treasuries
Healthcare
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AUR
Aurora Innovation, Inc.
Below Treasuries
Technology Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +150.0%/yr vs model +2.0% · above model
AURA
Aura Biosciences, Inc.
Below Treasuries
Healthcare Risk 39 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AURE
Aurelion Inc.
Below Treasuries
Financial Services Risk 46 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +41.0%/yr vs model +2.0% · above model
AUROW
Aurora Innovation, Inc.
Below Treasuries
Technology Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +57.2%/yr vs model +2.0% · above model
AUST
Austin Gold Corp.
Below Treasuries
Basic Materials Risk 30 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AUTL
Autolus Therapeutics plc
Below Treasuries
Healthcare Risk 36 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +34.2%/yr vs model +15.0% · above model
AUUD
AUDDIA INC.
Below Treasuries
Technology Risk 43 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AVAL
Grupo Aval Acciones Y Valores S.A.
Below Treasuries
Financial Services Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AVAV
AeroVironment Inc
Below Treasuries
Industrials Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +24.2%/yr vs model +20.1% · above model
AVBP
ArriVent BioPharma, Inc.
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AVEX
AEVEX Corp.
Below Treasuries
Industrials Risk 46 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AVGO
Broadcom Inc.
Below Treasuries
Technology Risk 28 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +31.9%/yr vs model +23.5% · above model
AVIR
Atea Pharmaceuticals, Inc.
Below Treasuries
Healthcare Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -2.4%/yr vs model +15.0% · below model
AVK
ADVENT CONVERTIBLE & INCOME FUND
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AVLN
Avalyn Pharma Inc.
Below Treasuries
Healthcare Risk 51 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AVR
Anteris Technologies Global Corp.
Below Treasuries
Healthcare Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +117.9%/yr vs model +2.0% · above model
AVTX
Avalo Therapeutics, Inc.
Below Treasuries
Healthcare Risk 34 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +142.3%/yr vs model +2.0% · above model
AVX
AVAX ONE TECHNOLOGY LTD.
Below Treasuries
Financial Services Risk 29 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +150.0%/yr vs model +27.8% · above model
AVXL
ANAVEX LIFE SCIENCES CORP.
Below Treasuries
Healthcare Risk 44 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AVY
Avery Dennison Corp
Bond-like
Basic Materials Risk 40 · Elevated
Yield5.0%
Growth used3.0%
10-yr IRR5.9%
Steady compounder · 4 yrs positive P/IV —
Market implies +5.2%/yr vs model +3.0% · in line
AWF
ALLIANCEBERNSTEIN GLOBAL HIGH INCOME FUND INC
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AWP
abrdn Global Premier Properties Fund
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AXG
Solowin Holdings, Ltd.
Below Treasuries
Financial Services Risk 29 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +48.8%/yr vs model +2.0% · above model
AXIA
AXIA Energia S.A.
Below Treasuries
Utilities
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AXIN
Axiom Intelligence Acquisition Corp 1
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AXINR
Axiom Intelligence Acquisition Corp 1
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AXON
AXON ENTERPRISE, INC.
Below Treasuries
Industrials Risk 47 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +27.2%/yr vs model +34.0% · below model
AXSM
Axsome Therapeutics, Inc.
Below Treasuries
Healthcare Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +18.8%/yr vs model +15.0% · above model
AXTI
AXT INC
Below Treasuries
Technology Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +87.2%/yr vs model +2.0% · above model
AYA
Aya Gold & Silver Inc.
Below Treasuries
Basic Materials
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AZ
A2Z CUST2MATE SOLUTIONS CORP.
Below Treasuries
Industrials Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AZI
Autozi Internet Technology (Global) Ltd.
Below Treasuries
Industrials
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AZN
ASTRAZENECA PLC
Below Treasuries
Healthcare
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
AZTA
Azenta, Inc.
Below Treasuries
Industrials Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +34.3%/yr vs model +8.4% · above model
AZTR
Azitra, Inc.
Below Treasuries
Healthcare Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +50.2%/yr vs model +15.0% · above model
AZZ
AZZ INC
Demanding to believe
Industrials Risk 41 · Elevated
Yield6.1%
Growth used15.0%
10-yr IRR17.9%
Grower · 5 yrs positive P/IV —
Market implies -2.0%/yr vs model +25.0% · below model
BA
BOEING CO
Below Treasuries
Industrials Risk 46 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +51.2%/yr vs model +8.0% · above model
BABA
Alibaba Group Holding Ltd
Below Treasuries
Technology Risk 44 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +31.0%/yr vs model +2.5% · above model
BACC
Blue Acquisition Corp/Cayman
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
BACCR
Blue Acquisition Corp/Cayman
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
BAK
BRASKEM SA
Below Treasuries
Basic Materials Risk 46 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
BAM
Brookfield Asset Management Ltd.
Below Treasuries
Financial Services Risk 43 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
BANX
ArrowMark Financial Corp.
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
BAP
CREDICORP LTD
Below Treasuries
Financial Services Risk 41 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
BAR
GraniteShares Gold Trust
Below Treasuries
Financial Services Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
BARK
Bark, Inc.
Below Treasuries
Consumer Cyclical Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +27.4%/yr vs model +6.3% · above model
BAVA
Bitwise Avalanche ETF
Below Treasuries
Financial Services Risk 51 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
BAYA
Bayview Acquisition Corp
Below Treasuries
Financial Services Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
BAYAR
Bayview Acquisition Corp
Below Treasuries
Financial Services Risk 35 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
BB
BLACKBERRY Ltd
Below Treasuries
Technology Risk 30 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +26.8%/yr vs model +2.0% · above model
BBAI
BigBear.ai Holdings, Inc.
Below Treasuries
Technology Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +61.3%/yr vs model +2.0% · above model
BBAR
Banco BBVA Argentina S.A.
Below Treasuries
Financial Services Risk 52 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —